Recognition of impairment losses on investment securities
First written in FY2017-Q1. 11 of 19 entries say "Restated". Latest entry: FY2025.
Neturen moved to the "Worse" side of this theme in 2019, 4 years before the typical company in this theme (2023).
The whole theme swung hardest in 2026: 35 of 81 companies on the "Worse" side.
39 other companies' latest entry also says "Mitigated".
- FY2025MitigatedAnnual report
「Securities subject to impairment losses: None applicable.」
No impairment loss on investment securities was recorded during the consolidated fiscal year, and no recurrence of impairment losses incurred in prior fiscal years is reported. - FY2024-Q2RestatedAnnual report
「During the cumulative second quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that management recognizes could materially affect the financial position, operating results and cash flows of the consolidated companies, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」
The company states that there have been no material changes in existing business and other risks, including impairment losses on investment securities. - FY2024-Q1RestatedAnnual report
「During the three-month period ended 30 June, there were no new risks that management recognizes as having the potential to materially affect the financial position, operating results or cash flows of the consolidated companies, and no material changes to the business risks described in the annual securities report for the previous fiscal year.」
The company states that there have been no material changes in existing business and other risks, including impairment losses on investment securities. - FY2023MitigatedAnnual report
「Securities subject to impairment losses: None applicable.」
No impairment loss on investment securities was recorded during the consolidated fiscal year, and no recurrence of impairment losses incurred through the previous fiscal year is reported. - FY2022MitigatedAnnual report
「Securities subject to impairment losses: None applicable.」
No impairment loss on investment securities was recorded during the consolidated fiscal year, and no recurrence of impairment losses incurred in prior fiscal years is reported. - FY2022-Q3RestatedAnnual report
「During the cumulative third quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that management recognizes could materially affect the financial position, operating results and cash flows of the consolidated companies, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」
The company states that there have been no material changes in existing business and other risks, including impairment losses on investment securities. - FY2021MitigatedAnnual report
「Securities subject to impairment losses: None applicable.」
No impairment loss on investment securities was recorded during the consolidated fiscal year, and no recurrence of the impairment loss recorded in the previous fiscal year is reported. - FY2021-Q3RestatedAnnual report
「During the cumulative third quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that could materially affect investors’ decisions, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」
The company states that there have been no material changes in existing business and other risks, including impairment losses on investment securities. - FY2020MaterialisedAnnual report
「During the consolidated fiscal year, the company recorded impairment losses of ¥209 million on securities, consisting of ¥209 million on shares classified as other securities.」
An impairment loss on investment securities of ¥209 million was recorded, and the risk of impairment losses materialized during the consolidated fiscal year. - FY2020-Q3RestatedAnnual report
「Impairment losses on investment securities —」
No impairment loss on investment securities was recorded during the nine months ended the third quarter, and no recurrence of the impairment loss incurred in the previous fiscal year is reported. - FY2019RestatedAnnual report
「Impairment loss on investment securities 464」
An impairment loss on investment securities of ¥464 million was recorded during the consolidated fiscal year, and the risk of impairment losses materialized as an extraordinary loss for the full fiscal year. - FY2019-Q3MaterialisedAnnual report
「As the company recorded an impairment loss on investment securities of ¥479 million as an extraordinary loss, among other factors, quarterly net income attributable to owners of the parent was ¥1,664 million, down 17.2% year on year.」
An impairment loss on investment securities of ¥479 million was recorded as an extraordinary loss. No such impairment loss was recorded in the nine months ended the third quarter of the previous fiscal year. - FY2019-Q2RestatedAnnual report
「During the cumulative second quarter of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The company states that there have been no material changes in business and other risks, including existing risks related to impairment losses on investment securities. - FY2019-Q1RestatedAnnual report
「During the first quarter of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The company states that there have been no material changes in business and other risks, including existing risks related to impairment losses on investment securities. - FY2018-Q3RestatedAnnual report
「Impairment losses on investment securities —」
No impairment loss on investment securities was recorded during the nine months ended the third quarter, and no recurrence of previously recorded impairment losses is reported. - FY2018-Q2RestatedAnnual report
「Impairment losses on investment securities —」
No impairment loss on investment securities was recorded during the six months ended the second quarter, and no recurrence of previously recorded impairment losses is reported. - FY2017-Q3RestatedAnnual report
「Loss on valuation of investment securities 0」
The impairment loss on investment securities for the nine months ended the third quarter was ¥0 million, and no recurrence of the impairment loss recorded in the previous fiscal year is reported. - FY2017-Q2MitigatedAnnual report
「Loss on valuation of investment securities 0」
The impairment loss on investment securities for the six months ended the second quarter was ¥0 million, and the ¥619 million impairment loss recorded in the previous quarter did not recur. - FY2017-Q1MaterialisedAnnual report
「As the company recorded an impairment loss on investment securities of ¥619 million as an extraordinary loss, among other factors, net loss attributable to owners of the parent was ¥167 million, compared with profit of ¥441 million in the same period of the previous year.」
An impairment loss on investment securities actually occurred, and ¥619 million was recorded as an extraordinary loss.